Inhibition of Mouse and Human Class 1 Aldehyde Dehydrogenase by 4-(N,N-Dialkylamino)Benzaldehyde Compounds

  • James E. Russo


The pharmacologic inhibition of the oxidation of aldehydes by aldehyde dehydrogenase (ALDH) has been pursued for over forty years. Disulfiram was first used clinically in an attempt to deter people from ethanol consumption (Hald and Jacobsen, 1948). Disulfiram inhibits the ALDH-catalyzed oxidation of acetaldehyde to acetate, resulting in the accumulation of the more toxic aldehyde metabolite. Unfortunately, disulfiram not only inhibits ALDH enzymes in the liver and erythrocytes, but it also interacts with reactive cysteine thiol side chains of other enzymes. Although identification of the active metabolite responsible for enzyme inhibition in vivo has proven difficult, bioactivation of disulfiram appears to be essential. While strong evidence has been presented that S-methyl N,N-diethylthiocarbamate sulfoxide is the disulfiram metabolite which acts as the in vivo inhibitor of rat liver mitochondrial ALDH (Hart and Faiman, 1992), the sulfone product has also been identified as a potent, irreversible inhibitor and potential in vivo metabolite of disulfiram (Mays et al, 1995).


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Boyer, C.S., and Petersen, D.R. The Metabolism of 3,7-dimethyl-2,6-octadienal (citral) in rat hepatic mitochondrial and cytosolic fractions. Drug. Metab. Dispos. 19: 81–86, 1991.PubMedGoogle Scholar
  2. Bunting, K.D. and Townsend, A.J. De Novo Expression of Transfected Human Class 1 Aldehyde Dehydrogenase (ALDH) Causes Resistance to Oxazaphosphorine Anti-cancer Alkylating Agents in Hamster V79 Cell Lines. J. Biol. Chem. 271:11884–11890, 1996a.PubMedCrossRefGoogle Scholar
  3. Bunting, K.D. and Townsend, A.J. Protection by Transfected Rat or Human Class 3 Aldehyde Dehydrogenasse against the Cytotoxic Effect of Oxazaphosphorine Alkylating Agents in Hamster V79 Cell Lines. J. Biol. Chem. 271:11892–11896, 1996b.CrossRefGoogle Scholar
  4. Crow, K.E., Kitson, T.M., MacGibbon, A.K.H., and Batt, R.D. Intracellular localization and properties of aldehyde dehydrogenases from sheep liver. Biochim. et Biophys. Acta 350: 121–128, 1974.CrossRefGoogle Scholar
  5. Dockham, P.A., Lee, M.O., and Sladek, N.E. Identification of Human Liver Aldehyde Dehydrogenases that Catalyze the Oxidation of Aldophosphamide and Retinaldehyde. Biochem. Pharmacol. 43: 2453–2469, 1992.PubMedCrossRefGoogle Scholar
  6. Hald, J. and Jacobsen, E. A drug sensitizing the organism to ethyl alcohol. Lancet 2: 1001–1004, 1948.PubMedCrossRefGoogle Scholar
  7. Hart, B.W. and Faiman, M.D. In vitro and in vivo inhibition of rat liver aldehyde dehydrogenase by S-methyl N,N-diethylthiolcarbamate sulfoxide, a new metabolite of disulfiram. Biochem. Pharmacol. 43:403–406, 1992.PubMedCrossRefGoogle Scholar
  8. Jones, R.J., Barber, J.P., Vala, M.S., Collector, M.I., Kaufmann, S.H., Ludeman, S.M., Colvin, O.M., and Hilton, J. Assessment of Aldehyde Dehydrogenase in Viable Cells. Blood 85:2742–2746, 1995.PubMedGoogle Scholar
  9. Kastan, M.B., Schlaffer, E., Russo, J.E., Colvin, O.M., Civin, C.I., and Hilton, J. Direct Demonstration of Elevated Aldehyde Dehydrogenase in Human Hematopoietic Progenitor Cells. Blood 75:1947–1950, 1990.PubMedGoogle Scholar
  10. Keung, W.M., and Vallee, B.L. Daidzin: A potent, selective inhibitor of human mitochondrial aldehyde dehydrogenase. Proc. Natl. Acad. Sci. USA 90: 1247–1251, 1993a.PubMedCrossRefGoogle Scholar
  11. Keung, W.M. and Vallee, B.L. Daidzin and daidzein suppress free-choice ethanol intake by Syrian Golden Hamsters. Proc. Natl. Acad. Sci. USA 90: 10008–10012, 1993b.PubMedCrossRefGoogle Scholar
  12. Kohn, F.R., Landkamer, G.J., Manthey, C.L., Ramsay, N.K., and Sladek, N.E. Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines. Cancer. Res. 47:3180–3185, 1987.PubMedGoogle Scholar
  13. Kohn, F.R. and Sladek, N.E. Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines. Biochem. Pharmacol. 34:3465–3471, 1985.PubMedCrossRefGoogle Scholar
  14. Maki, P.A. and Sladek, N.E. Sensitivity of aldehyde dehydrogenases in murine tumor and hematopoietic progenitor cells to inhibition by chloral hydrate as determined by the ability of chloral hydrate to potentiate the cytotoxic action of mafosfamide. Biochem. Pharmacol. 45:231–239, 1993.PubMedCrossRefGoogle Scholar
  15. Mahmoud, M.I.E., Potter, J.J., Colvin, O.M., Hilton, J., and Mezey, E. Effect of 4-(diethylamino)benzaldehyde on ethanol metabolism in mice. Alcohol Clin. Exp. Res. 17: 1223–1227, 1993.PubMedCrossRefGoogle Scholar
  16. Mays, D.C., Nelson, A.N., Fauq, A.H., Shriver, Z.H., Veverka, K.A., Naylor, S., and Lipsky, J.J. S-Methyl N,N-Diethylthiocarbamate Sulfone, A potential Metabolite of Disulfiram and Potent Inhibitor of Low Km Mitochondrial Aldehyde Dehydrogenase. Biochem. Pharmacol. 49: 693–700, 1995.PubMedCrossRefGoogle Scholar
  17. Mukerjee, N. and Pietruszko, R. Inactivation of Human Aldehyde Dehydrogenase by Isosorbide Dinitrate. J. Biol. Chem. 269:21664–21669, 1994.PubMedGoogle Scholar
  18. Nagasawa, H.T., Yost, Y., Elberling, J.A., Shirota, F.N., and Demaster, E.G. Nitroxyl analogs as inhibitors of aldehyde dehydrogenase. Biochem. Pharmacol. 45: 2129–2134, 1993.PubMedCrossRefGoogle Scholar
  19. Poole, R.C., Bowden, N.J., and Halestrap, A.P. Derivatives of cinnamic acid interact with the nucleotide binding site of mitochondrial aldehyde dehydrogenase. Biochem. Pharmacol. 45: 1621–1630, 1993.Google Scholar
  20. Rekha, G.K., Sreerama, L., and Sladek, N.E. Intrinsic Cellular Resistance to Oxazaphosphorines Exhibited by a Human Colon Carcinoma Cell Line Expressing Relatively Large Amounts of a Class-3 Aldehyde Dehydrogenase. Biochem. Pharmacol. 48:1943–1952, 1994.PubMedCrossRefGoogle Scholar
  21. Russo, J.E., Hauquitz, D., and Hilton, J. Inhibition of mouse cytosolic aldehyde dehydrogenase by 4-(diethylamino)benzaldehyde. Biochem. Pharmacol. 37:1639–1642, 1988.PubMedCrossRefGoogle Scholar
  22. Russo, J.E., Hilton, J., and Colvin, O.M. The Role of Aldehyde Dehydrogenase Isozymes in Cellular Resistance to the Alkylating Agent Cyclophosphamide. In: Enzymology and Molecular Biology of Carbonyl Metabolism 2. Flynn, T.G. and Weiner, H.,) pp. 65–79. Alan R. Liss, New York 1989.Google Scholar
  23. Russo, J., Chung, S., Contreras, K., Lian, B., Lorenz, J., Stevens, D., and Trousdell, W. Identification of 4-(N,N-dipropylamino)benzaldehyde as a potent, reversible inhibitor of mouse and human class I aldehyde dehydrogenase. Biochem.Pharmacol. 50: 399–406, 1995.PubMedCrossRefGoogle Scholar
  24. Sahovic, E.A., Colvin, M., Hilton, J., and Ogawa, M. Role for aldehyde dehydrogenase in survival of progenitors for murine blast cell colonies after treatment with 4-hydroperoxycyclophosphamide in vitro. Cancer Res. 48: 1223–1226, 1988.PubMedGoogle Scholar
  25. Sladek, N.E., Sreerama, L., and Rekha, G.K. Constitutive and Overexpressed Human Cytosolic Class-3 Aldehyde Dehydrogenases in Normal and Neoplastic Cells/Secretions. In Enzymology and Molecular Biology of Carbonyl Metabolism 5; Weiner, H., Holmes, R.S., and Wermuth, B., eds. Plenum Press, N.Y. pp. 103–113, 1995.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • James E. Russo
    • 1
  1. 1.Department of ChemistryWhitman CollegeWalla WallaUSA

Personalised recommendations